| « Previous month | Next month » |
A new type of latex glove developed by Yulex Corp that is less allergenic for medical and research staff has been given a green light by the US Food and Drug Administration (FDA).
Lab901 has raised £3.5m in funding, which will go towards expanding its sales efforts and new products for RNA and Protein Electrophoresis - a market that is currently worth $1.3bn worldwide and expected to increase to over $1.6bn.
Invitrogen's first-quarter profits were nearly double those it recorded in the first-quarter of 2007.The maker of kits used for cloning enjoyed growth, driven by sharp increases in sales for drug discovery and research.
UK researchers have started developing a 'lung in a test tube', that could aid research into respiratory diseases such as asthma and allergy and reduce the need for animal testing.
The European Commission has urged member states to more effectively convert knowledge acquired through research into socio-economic benefits.
Analytical equipment specialists Waters made a solid start to 2008, posting a 12 per cent increase in first-quarter revenues buoyed on by higher margin expansions and strong global sales that build on previous quarterly performances.
The Bio Affinity Company (BAC) has introduced two new products for scientists who need to purify hard-to-separate antibodies such as immunogloblins A and M.
Researchers have created a hybrid gel that can reacts to changes in acidity and temperature by turning green. The gel, made from a combination of synthetic polymers and proteins, could be used as sensors, nanomachine parts or drug discovery systems.
Illumina unveils its next generation genetic analysis platform with the claim that it provides greater throughput, enhanced automation, and improved ease for researchers conducting genotyping and gene expression studies.
Researchers have found a way to isolate individual proteins in tiny droplets of water to create what is essentially a nano-scale test tube.
An intriguing new method which allows for more detailed electron microscopy images is set to shed light on the complex chromosomal structures that carry out DNA functions such as replication and transcription.
You'll be unlikely to see them at your local cinema, but molecular animations created using highly accurate information from X-ray scattering images, will help explain how proteins and organic molecules behave in a solution.
Frank Torti has been appointed to the newly created post of chief scientist at the FDA, with a brief to "oversee, coordinate, and ensure quality and regulatory focus of the intramural research programs".
The US Food and Drug Administration (FDA) has released a document in an attempt to harmonise pharmacogenomic definitions and sample coding guidance.
Febit has updated its Geniom microRNA analysis platform with the latest version of the Sanger Institute's database of all known miRNA elements. The upgrade should provide scientists with a more detailed microRNA profile of their samples.
VisEn Medical has launched a new version of its fluorescence molecular tomography platform for small animal imaging, the FMT 2500.
An $8.8m collaboration between two pharma companies and a leading university has resulted in a project that uses fragment-based crystallography and in silico fragment screening for lead identification.
GE Healthcare saw its first quarter earnings hit as stronger competition to its imaging equipment arm as US government-mandated reimbursement cuts had an impact.
LabTechnologist.com presents a round-up of new products that have been introduced to the laboratory equipment market of late, including items from Matrical, Millrock Technology, AnaSpec, Lab M and ibidi.
The proposed split of the Celera Group from its parent Applera Corporation to form a separate, publicly-traded company is gathering momentum with a preliminary prospectus now filed with the US Securities and Exchange Commission.
Buckyballs have the annoying tendency of sticking together in floating clumps in water - a property that prevents them from settling to be removed from waste water from industrial production.
Scientists have created the first extensive collection of antibodies known to target bird flu successfully. The "libraries" of antibodies found in bird flu survivors could be used to suggest desirable features in future antiviral drugs designed to combat the disease.
Researchers have genetically engineered normal skin cells into cancer stem cells - a previously elusive type of stem cell that are thought to drive cancer.
BioFocus DPI, a subsidiary of Galapagos, has launched a new platform for drug discovery at the Society for Biomolecular Sciences Annual Conference taking place this week in St Louis.
Scientists believe they may have found the key to eliminating stem cells that pose a cancerous threat when it comes to differentiation during the cell's life cycle.
A new set of draft guidelines aims to identify the core scientific competencies required by firms working in the UK's £3.3bn (€4.2bn) bioscience sector.
Two products aimed at enhancing the efficiency of process development in biopharmaceutical manufacturing are the latest offerings from GE Healthcare, the UK-based medical technology and services company.
LycoRed has launched a consumer-oriented website it hopes will boost worldwide lycopene awareness and understanding and add value to its present and future co-branding arrangements.
Scientists may be one step closer to the "holy grail" of $1,000 genetic sequencing, helped by a highly parallel sequencing-by-synthesis method of genetic sequencing that can read more than 280,000 individual DNA molecules simultaneously.
Geneart has been awarded a patent for its drug screening technology, which could aid the discovery of a new type of antiviral drug for HIV and other viruses.
The National Institutes of Health (NIH) has launched a unique initiative aimed at gathering opinion in the scientific community regarding opportunities and research gaps in order to advance the fields of pharmacogenomics and pharmacogenetics.
Thermo Fisher debuted several new laboratory products at Analytica with a focus on the liquid handling and microplate end of the laboratory market.
Amid fears that a bird flu epidemic could spark a black market of illegal counterfeit antiviral drugs, researchers have found a technique that could screen for fakes 20 times faster than previous methods.
Invitrogen has immersed itself in yet more legal wrangling after the life sciences firm filed a patent lawsuit against GE Healthcare alleging 'wilful' infringement of its intellectual property.
The Indian government has reacted to the enforced closure of three of its oldest vaccine manufacturing plants by launching a plan to convert them to drug testing laboratories.
Olympus is planning to expand its European operations with a €15m R&D centre in Munich, Germany, tasked with producing the next generation of in vitro lab diagnostics and laboratory automation equipment.
The Department of Pathology at Uppsala University Hospital in Sweden is evaluating Biotage's new pyrosequencing platform to detect a genetic biomarker that indicates how well a cancer patient will respond to targetted drug therapies.
ESA Biosciences has struck a deal with Waters Corp to produce a direct interface for ESA's HPLC detector that allows it to fully integrate with Waters' chromatography control and data-analysis platform.
A new research institute, which aims to investigate the role of the human immune system in diseases such as AIDS, cancer and multiple sclerosis, has been founded by not-for-profit organisation the Immune Tolerance Institute and biomedical company Beckman Coulter.
The Asia Pacific region is poised to witness heightened activity in terms of outsourced drug development to contract research organisations (CROs), with India and China remaining the preferred destinations.
The 1,000 Genomes Project is to benefit from a powerful new computational tool which can analyse half a million DNA sequences within ten minutes.
With manufacturing productivity in the pharmaceutical sector widely acknowledged as being in need of modernisation, a US firm believes it has developed a technology that could carve days off the time spent on microbial testing, a cumbersome but ubiquitous part of the quality control process.
A new laboratory technique can describe both the structure and chemical composition of samples with a mass of less than one femtogram (one quadrillionth of a gram) using standard laboratory equipment.
Epigenomics and TIB Molbiol unveiled new products for DNA methylation analysis at Analytica in Munich this week, providing new tools for research into prostate, colorectal and other cancers.
Waters Corp unveiled a new concept in Process Analytical Technology (PAT) at Pittcon 2008 when it released the new Patrol UPLC (ultra performance liquid chromatography) process analyser, which can be incorporated directly into a process.
Syft Technologies of New Zealand released the latest generation of Selected Ion Flow Tube-Mass Spectrometry (SIFT) instrumentation at Pittcon 2008 for the analysis of very low levels of organic compounds in air (detection limits as low as 50 parts per trillion).
Life sciences equipment company Millipore says its new protein detection system, SNAP i.d, can improve the time it takes to carry out Western blots by as much as 80 per cent compared to conventional immunodetection methods.
Researchers have found two key proteins at the centre of sexual reproduction which allow two sex cells to merge and form a zygote. The discovery suggests a new way of preventing the spread of malaria by inhibiting its reproduction in the belly of the mosquito.
Quintiles has forged a new partnership that will allow it to begin providing central laboratory services in Japan, where the clinical research organisation (CRO) industry is gaining momentum.
| « Previous month | Next month » |